AstraZeneca to sell Synagis US rights to Sobi for $1.5bn

Synagis is indicated for the prevention of serious lower respiratory tract infection (LRTI) caused by respiratory syncytial virus (RSV) in highly prone infants and is the only approved The post AstraZeneca to sell Synagis US rights to Sobi for $1.5bn appeared first on Pharmaceutical Business review.

Sen. Grassley grills FDA on cybersecurity improvements

US Senate Committee on the Judiciary chair Sen. Chuck Grassley (R-IA) recently sent a letter to FDA head Dr. Scott Gottlieb grilling them on steps the agency has taken to improve its oversight and reaction time in relation to cybersecurity threats. In the letter, written on behalf of the Committee, Grassley references a report sent […]

FDA warns on pain drugs for implantable pumps

The FDA today warned doctors and patients about the serious complications that can occur when using the wrong painkillers with implantable drug pumps. Dosing errors, pump failure, and infection are just some of the potential problems that can crop up when using drugs that aren’t approved for use with particular devices, the regulatory agency said. […]

Cochlear joins $17m round for sleep apnea nueromod dev Nyxoah

Cochlear Ltd. (ASX:COH) has joined a $17.1 million (EU €15 million) funding round for Nyxoah to support the development and commercialization of its hypoglossal nerve stim therapy for treating obstructive sleep apnea. Australian hearing tech developer Cochlear lead the round, investing $14.7 million (EU €13 million). The round was also joined by several existing Nyxoah shareholders, […]

Report: Med device recalls down in Q3

Medical device recalls fell by 21% to 284 in the third quarter of 2018, according to a report by Stericycle Expert Solutions. Machine failure was the top cause of recalls based on units, while software led the way based on numbers of recalls, the report says. The total number of medtech recalls for Q3 was lower […]

Merit Medical closes $200m Cianna Medical buy

Merit Medical (NSDQ:MMSI) said yesterday that it closed its $200 million acquisition of Cianna Medical, making the company a wholly-owned subsidiary. Aliso Viejo, Calif.-based Cianna makes the Savi Scout wire-free breast tumor localization system, designed to produce audible and visual indicators surgeons can use to tag cancerous tissue during lumpectomy and biopsy procedures. The device won 510(k) clearance from […]

Aegea Medical raises $17m, touts 3-year adaptive vapor ablation pivotal results

Aegea Medical said this week it raised $17 million in a new financing round and released three-year follow-up data from the pivotal study of its Adaptive Vapor Ablation technology designed for use in endometrial ablation procedures. The funding round was led by Solas BioVentures and its affiliates, with funds slated to support the company’s PACE II […]

Baxter expands share repurchase program to $3.4B

Baxter (NYSE:BAX) said yesterday that it expanded its share purchase program to $3.4 billion. The Deerfield, Ill.-based company approved a $2 billion increase in authorization for the company’s existing share repurchase plan. Baxter also declared a quarterly cash dividend of 19¢ per share of common stock to stockholders as of Dec 3, payable on Jan. 2, of […]

How a teenage Gary Guthart, Intuitive Surgical’s CEO, got his start at NASA

Today Gary Guthart is best know as the CEO of Intuitive Surgical (NSDQ:ISRG), the world’s leading medical robotics company. But robot-assisted surgery wasn’t Guthart’s first love, he told ahead of his keynote appearance at this year’s DeviceTalks West event. That honor goes to NASA (or, more properly, science). During his teenage years growing up in […]

Varex shares fall on Q4 miss

Shares in Varex Imaging (NSDQ:VREX) fell today after the company missed earnings expectations on Wall Street with its fourth-quarter financial results. The Salt Lake City, Utah-based company posted profits of $200,000, or 1¢ per share, on sales of $204.8 million for the three months ended Sept. 28, for a sales loss of 5% compared with the […]